Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AIMT

Aimmune Therapeutics (AIMT)

Aimmune Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AIMT
DateTimeSourceHeadlineSymbolCompany
02/25/20219:00AMBusiness WireAimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 YearsNASDAQ:AIMTAimmune Therapeutics Inc
02/16/20214:19PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AIMTAimmune Therapeutics Inc
12/21/20201:15AMBusiness WireEuropean Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EUNASDAQ:AIMTAimmune Therapeutics Inc
10/23/20201:12PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AIMTAimmune Therapeutics Inc
10/19/20205:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/14/20204:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:32PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:31PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:31PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:30PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:30PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:30PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:29PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20205:29PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/202010:49AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/202010:45AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/202010:45AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20209:15AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AIMTAimmune Therapeutics Inc
10/13/20202:15AMDow Jones NewsNestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With SubsidiaryNASDAQ:AIMTAimmune Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AIMT

Your Recent History

Delayed Upgrade Clock